IMVT vs MNDY · $2.90B cap vs P/E 32, rev $1.23B
Immunovant Inc (IMVT) versus Monday.Com Ltd (MNDY) — a side-by-side from cached financials, not a winner call.
Immunovant Inc (IMVT) is a biotechnology company listed on US.
Monday.Com Ltd (MNDY) is a software - application company listed on US.
IMVT does not have a complete income-statement cache yet.
Latest reported MNDY revenue for 2025-12-31 was $1.23B. Net income was $118.7M. Revenue was up 26.7% from 2024-12-31 to 2025-12-31. MNDY currently screens at market cap $3.79B and trailing P/E 32.1.
IMVT currently screens at market cap $2.90B. MNDY currently screens at market cap $3.79B and trailing P/E 32.1.
Not investment advice. Open the IMVT and MNDY stock pages for the full models.
Not investment advice.